Health TrialsbyHealthPanel

Clinical Registry for the Characterization of the 'Pulmonary Vascular Phenotype' in Patients With Chronic Obstructive Pulmonary Disease

ConditionsChronic Obstructive Pulmonary Disease (COPD)Pulmonary Hypertension
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMedical University of Graz

About this trial

Registry of COPD (Chronic Obstructive Pulmonary Disease) patients who underwent right heart catheterization (RHC) and full clinical evaluation for pulmonary hypertension

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

clinical diagnosis of COPD

right heart catheterization including mPAP (Mean Pulmonary Artery Pressure), PVR (Pulmonary Vascular Resistance), PAWP (Pulmonary Artery Wedge Pressure), CO (cardiac output)

age >= 18 years

Disqualifiers

pediatric patients

no COPD or no RHC

Trial population

COPD patients who underwent RHC

Trial design

Design model

Cohort

Time perspective

Retrospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Severe Pulmonary Hypertension (PH)

pulmonary vascular resistance \> 5 WU (Wood Units)

Time frame
at inclusion
2

all-cause mortality

all-cause mortality

Time frame
Until 2026

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Medical University of Graz

Lead sponsor

Source ClinicalTrials.gov
Apply now